NLRP3 and metabolic dysfunction-associated steatotic liver disease: In NAFLD patients who have fatty liver but no inflammation, the expression of NLRP3 components is increased, but the inflammasome is not activated; however, in patients with fatty liver and inflammation, the NLRP3 inflammasome complex is assembled and functional [106].